CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
episil wound dressing +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03350724
NCT03350724N/ACompleted
CompareCT.gov

Randomized Controlled Clinical Trial Pilot Study: Patient Outcomes and Gingival Blood Flow Using Laser Doppler Flowmetry Following the Use of Episil on Free Gingival Graft Donor Sites

The University of Texas Health Science Center, Houston·interventional·Posted Nov 22, 2017·Updated Apr 17, 2018

In Brief

A clinical study evaluating episil wound dressing and PeriAcryl90 wound dressing for Pain From Free Gingival Graft. Completed, enrolled 34 participants across 1 site.

Detailed Summary

The hypothesis for the present study is that patient-based outcomes and gingival blood flow will be more favorable for the free gingival graft (FGG) donor sites being covered by the test wound dressing material episil compared to the control dressing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain From Free Gingival Graft
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 22, 2017
Enrollment StartOct 29, 2015
Primary CompletionMay 19, 2017
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 8.6 years ago

Interventions

episil wound dressingdevice

Episil is a wound dressing material intended for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. episil is an oromucosal liquid that transforms in situ to a bioadhesive oromucosal gel by uptake of small amounts of aqueous fluid.

PeriAcryl90 wound dressingdevice

PeriAcryl90 is a cyanoacrylate wound dressing.